263 related articles for article (PubMed ID: 17440703)
21. Measuring TREX1 and TREX2 exonuclease activities.
Hemphill WO; Perrino FW
Methods Enzymol; 2019; 625():109-133. PubMed ID: 31455522
[TBL] [Abstract][Full Text] [Related]
22. Heterozygous TREX1 p.Asp18Asn mutation can cause variable neurological symptoms in a family with Aicardi-Goutieres syndrome/familial chilblain lupus.
Abe J; Izawa K; Nishikomori R; Awaya T; Kawai T; Yasumi T; Hiragi N; Hiragi T; Ohshima Y; Heike T
Rheumatology (Oxford); 2013 Feb; 52(2):406-8. PubMed ID: 22829693
[No Abstract] [Full Text] [Related]
23. Type I interferonopathies with novel compound heterozygous TREX1 mutations in two siblings with different symptoms responded to tofacitinib.
Zhang S; Song J; Yang Y; Miao H; Yang L; Liu Y; Zhang X; Liu Y; Wang T
Pediatr Rheumatol Online J; 2021 Jan; 19(1):1. PubMed ID: 33407657
[TBL] [Abstract][Full Text] [Related]
24. Inherited or de novo mutation affecting aspartate 18 of TREX1 results in either familial chilblain lupus or Aicardi-Goutières syndrome.
Tüngler V; Silver RM; Walkenhorst H; Günther C; Lee-Kirsch MA
Br J Dermatol; 2012 Jul; 167(1):212-4. PubMed ID: 22356656
[No Abstract] [Full Text] [Related]
25. Biochemical properties of mammalian TREX1 and its association with DNA replication and inherited inflammatory disease.
Lindahl T; Barnes DE; Yang YG; Robins P
Biochem Soc Trans; 2009 Jun; 37(Pt 3):535-8. PubMed ID: 19442247
[TBL] [Abstract][Full Text] [Related]
26. Photosensitivity and cGAS-Dependent IFN-1 Activation in Patients with Lupus and TREX1 Deficiency.
Berndt N; Wolf C; Fischer K; Cura Costa E; Knuschke P; Zimmermann N; Schmidt F; Merkel M; Chara O; Lee-Kirsch MA; Günther C
J Invest Dermatol; 2022 Mar; 142(3 Pt A):633-640.e6. PubMed ID: 34400195
[TBL] [Abstract][Full Text] [Related]
27. A TREX1 mutation causing cerebral vasculopathy in a patient with familial chilblain lupus.
Yamashiro K; Tanaka R; Li Y; Mikasa M; Hattori N
J Neurol; 2013 Oct; 260(10):2653-5. PubMed ID: 23989343
[No Abstract] [Full Text] [Related]
28. Familial chilblain lupus, a monogenic form of cutaneous lupus erythematosus, maps to chromosome 3p.
Lee-Kirsch MA; Gong M; Schulz H; Rüschendorf F; Stein A; Pfeiffer C; Ballarini A; Gahr M; Hubner N; Linné M
Am J Hum Genet; 2006 Oct; 79(4):731-7. PubMed ID: 16960810
[TBL] [Abstract][Full Text] [Related]
29. Chilblain lupus erythematosus--a review of literature.
Hedrich CM; Fiebig B; Hauck FH; Sallmann S; Hahn G; Pfeiffer C; Heubner G; Lee-Kirsch MA; Gahr M
Clin Rheumatol; 2008 Aug; 27(8):949-54. PubMed ID: 18543054
[TBL] [Abstract][Full Text] [Related]
30. Systemic lupus erythematosus overlapping dermatomyositis owing to a heterozygous TREX1 Asp130Asn missense mutation.
Endo Y; Koga T; Otaki H; Furukawa K; Kawakami A
Clin Immunol; 2021 Jun; 227():108732. PubMed ID: 33892200
[TBL] [Abstract][Full Text] [Related]
31. DNase-active TREX1 frame-shift mutants induce serologic autoimmunity in mice.
Sakai T; Miyazaki T; Shin DM; Kim YS; Qi CF; Fariss R; Munasinghe J; Wang H; Kovalchuk AL; Kothari PH; Fermaintt CS; Atkinson JP; Perrino FW; Yan N; Morse HC
J Autoimmun; 2017 Jul; 81():13-23. PubMed ID: 28325644
[TBL] [Abstract][Full Text] [Related]
32. Human disease phenotypes associated with mutations in TREX1.
Rice GI; Rodero MP; Crow YJ
J Clin Immunol; 2015 Apr; 35(3):235-43. PubMed ID: 25731743
[TBL] [Abstract][Full Text] [Related]
33. Familial chilblain lupus due to a gain-of-function mutation in STING.
König N; Fiehn C; Wolf C; Schuster M; Cura Costa E; Tüngler V; Alvarez HA; Chara O; Engel K; Goldbach-Mansky R; Günther C; Lee-Kirsch MA
Ann Rheum Dis; 2017 Feb; 76(2):468-472. PubMed ID: 27566796
[TBL] [Abstract][Full Text] [Related]
34. cGAS activation causes lupus-like autoimmune disorders in a TREX1 mutant mouse model.
Xiao N; Wei J; Xu S; Du H; Huang M; Zhang S; Ye W; Sun L; Chen Q
J Autoimmun; 2019 Jun; 100():84-94. PubMed ID: 30872080
[TBL] [Abstract][Full Text] [Related]
35. Aicardi-Goutières syndrome protein TREX1 suppresses L1 and maintains genome integrity through exonuclease-independent ORF1p depletion.
Li P; Du J; Goodier JL; Hou J; Kang J; Kazazian HH; Zhao K; Yu XF
Nucleic Acids Res; 2017 May; 45(8):4619-4631. PubMed ID: 28334850
[TBL] [Abstract][Full Text] [Related]
36. [Familial chilblain lupus: Four cases spanning three generations].
Beltoise AS; Audouin-Pajot C; Lucas P; Tournier E; Rice GI; Crow YJ; Mazereeuw-Hautier J
Ann Dermatol Venereol; 2018 Nov; 145(11):683-689. PubMed ID: 30217686
[TBL] [Abstract][Full Text] [Related]
37. New roles for the major human 3'-5' exonuclease TREX1 in human disease.
Kavanagh D; Spitzer D; Kothari PH; Shaikh A; Liszewski MK; Richards A; Atkinson JP
Cell Cycle; 2008 Jun; 7(12):1718-25. PubMed ID: 18583934
[TBL] [Abstract][Full Text] [Related]
38. The exonuclease TREX1 is in the SET complex and acts in concert with NM23-H1 to degrade DNA during granzyme A-mediated cell death.
Chowdhury D; Beresford PJ; Zhu P; Zhang D; Sung JS; Demple B; Perrino FW; Lieberman J
Mol Cell; 2006 Jul; 23(1):133-42. PubMed ID: 16818237
[TBL] [Abstract][Full Text] [Related]
39. TREX1 variants in Sjogren's syndrome related lymphomagenesis.
Nezos A; Makri P; Gandolfo S; De Vita S; Voulgarelis M; Crow MK; Mavragani CP
Cytokine; 2020 Aug; 132():154781. PubMed ID: 31326279
[TBL] [Abstract][Full Text] [Related]
40. Typing TREX1 gene in patients with systemic lupus erythematosus.
Fredi M; Bianchi M; Andreoli L; Greco G; Olivieri I; Orcesi S; Fazzi E; Cereda C; Tincani A
Reumatismo; 2015 Jun; 67(1):1-7. PubMed ID: 26150267
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
